earnings
Operational Portfolio Outperforms: Legal Decisions Clear Growth Path (PFE Q1 2026 Earnings Call)
Pfizer started the fiscal year with strong operational momentum, demonstrating robust core portfolio demand and securing key legal settlements that clear a path for long-term expansion.